Transcriptional control of human p53-regulated genes
Abstract
The p53 protein regulates the transcription of many different genes in response to a wide variety of stress signals. Following DNA damage, p53 regulates key processes, including DNA repair, cell-cycle arrest, senescence and apoptosis, in order to suppress cancer. This Analysis article provides an overview of the current knowledge of p53-regulated genes in these pathways and others, and the mechanisms of their regulation. In addition, we present the most comprehensive list so far of human p53-regulated genes and their experimentally validated, functional binding sites that confer p53 regulation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
p53 functions primarily as a transcription factor.
“The tumor suppressor p53 functions primarily as a transcription factor.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
The prevailing function of the p53 tumor suppressor is the transcriptional control of target genes that regulate numerous cellular processes, including cell cycle and apoptosis.
“The prevailing function of the p53 tumor suppressor is the transcriptional control of target genes that regulate numerous cellular processes, including cell cycle and apoptosis.5, 6”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
p53 is mutated in more than 50% of human cancers.
“p53 is an crucial tumor suppressor that is mutated in more than 50% of human cancers”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Riley et al., 2008
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works
Self-citationVogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works
Self-citationEddy, S. R. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.9.755 · Cited by 5,515 · see citing works
Sequence logos: a new way to display consensus sequences
Schneider, T. D., & Stephens, R. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.20.6097 · Cited by 3,396 · see citing works
Durbin, R. M., Eddy, S. R., Krogh, A., & Mitchison, G. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511790492 · Cited by 3,255 · see citing works
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · see citing works
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1× · see citing works
“On the basis of X-ray crystallography studies of the p53 DNA-binding core domain bound to a p53-RE DNA sequence, the most important bases for interactions with the p53 protein are the central RCWWGY, which come into close contact with the amino acids from the p53 core domai”
BackgroundHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,211 · see citing works
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079 · see citing works
Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
Yeo, G. W.-M., & Burge, C. B. (2004) · Journal of Computational Biology · doi:10.1089/1066527041410418 · Cited by 2,042 · see citing works
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · see citing works
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967 · see citing works
Self-citationHidden Markov Models in Computational Biology
Krogh, A., Brown, M., Mian, S. I., Sjölander, K. V., & Haussler, D. H. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1104 · Cited by 1,948 · see citing works
DNA binding sites: representation and discovery
Stormo, G. D. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.1.16 · Cited by 1,519 · see citing works
Shukla, S., Mishra, B., Avashthi, H., & Chandra, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-89775-4.00003-1 · Cited by 1,513 · see citing works
Assessing computational tools for the discovery of transcription factor binding sites
Tompa, M., Li, N., Bailey, T. L., Church, G. M., De Moor, B., Eskin, E., Favorov, A. V., Frith, M. C., Fu, Y., Kent, W. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1053 · Cited by 1,268 · see citing works
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265 · see citing works
Self-citationIs a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251 · see citing works
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235 · see citing works
Self-citationApplied bioinformatics for the identification of regulatory elements
Wasserman, W. W., & Sandelin, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1315 · Cited by 1,206 · see citing works
Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,162 · see citing works
A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141 · see citing works
DNA sequence-dependent deformability deduced from protein–DNA crystal complexes
Olson, W. K., Gorin, A. A., Lu, X., Hock, L. M., & Zhurkin, V. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11163 · Cited by 1,039 · see citing works
Interaction of the p53-Regulated Protein Gadd45 with Proliferating Cell Nuclear Antigen
Smith, M. L., Chen, I. T., Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., & Fornace, A. J. (1994) · Science · doi:10.1126/science.7973727 · Cited by 946 · see citing works
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940 · see citing works
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D. P., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 913 · see citing works
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904 · see citing works
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878 · see citing works
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R. L., Velasco-Miguel, S., Takenaka, I. M., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869 · see citing works
Regulation of p53 activity through lysine methylation
Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K. M., Tempst, P., Prives, C. L., Gamblin, S. J., et al. (2004) · Nature · doi:10.1038/nature03117 · Cited by 820 · see citing works
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D. G., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 801 · see citing works
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794 · see citing works
A Transcriptionally Active DNA-Binding Site for Human p53 Protein Complexes
Funk, W. D., Pak, D. T. S., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732 · see citing works
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710 · see citing works
The ubiquitin ligase COP1 is a critical negative regulator of p53
Dornan, D., Wertz, I. E., Shimizu, H., Arnott, D. P., Frantz, G. D., Dowd, P., Rourke, K. O., Koeppen, H., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02514 · Cited by 700 · see citing works
The Regulation of Exosome Secretion: a Novel Function of the p53 Protein
Yu, X., Harris, S. L., & Levine, A. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4579 · Cited by 688 · see citing works
Self-citationNPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcriptionPreprint
Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., & Harlow, E. (2000) · Genes & Development · doi:10.1101/gad.827700 · Cited by 665 · see citing works
The P53 pathway: what questions remain to be explored?
Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 654 · see citing works
Self-citationFeng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633 · see citing works
Self-citationAnalysis of p53-regulated gene expression patterns using oligonucleotide arraysPreprint
Zhao, R., Gish, K., Murphy, M. E., Yin, Y., Notterman, D. A., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 631 · see citing works
Self-citationSynergistic activation of transcription by CBP and p53
Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 596 · see citing works
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582 · see citing works
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J. A., Horikoshi, N., Weinmann, R. S., Levine, A. J., & Shenk, T. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504 · see citing works
Self-citationEllisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474 · see citing works
Murphy, M. E., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., & George, D. L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2490 · Cited by 455 · see citing works
Self-citationp53 regulates maternal reproduction through LIF
Hu, W., Feng, Z., Teresky, A. K., & Levine, A. J. (2007) · Nature · doi:10.1038/nature05993 · Cited by 446 · see citing works
Self-citationEspinosa, J. M., & Emerson, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00283-0 · Cited by 440 · see citing works
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R. D., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439 · see citing works
BID regulation by p53 contributes to chemosensitivity
Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., & El-Deiry, W. S. (2002) · Nature Cell Biology · doi:10.1038/ncb866 · Cited by 420 · see citing works
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo
Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R. G., & Gu, W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308762101 · Cited by 419 · see citing works
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418 · see citing works
Specificity, free energy and information content in protein–DNA interactions
Stormo, G. D., & Fields, D. S. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01187-6 · Cited by 367 · see citing works
Takimoto, R., & El-Deiry, W. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203489 · Cited by 360 · see citing works
Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis
Lin, Y., Ma, W., & Benchimol, S. (2000) · Nature Genetics · doi:10.1038/79102 · Cited by 353 · see citing works
Inhibition of Cyclooxygenase-2 Gene Expression by p53
Subbaramaiah, K., Altorki, N. K., Chung, W. J., MESTRE, J. R., Sampat, A., & Dannenberg, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10911 · Cited by 350 · see citing works
p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis
Okamura, S., Arakawa, H., Tanaka, T., Nakanishi, H., Ng, C. C., Taya, Y., Monden, M., & Nakamura, Y. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00284-2 · Cited by 348 · see citing works
Yang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605752103 · Cited by 341 · see citing works
Activation of the p53 tumor suppressor protein
Vousden, K. H. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00035-5 · Cited by 337 · see citing works
PML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312 · see citing works
The p53MH algorithm and its application in detecting p53-responsive genes
Hoh, J., Jin, S. V., Parrado, T., Edington, J., Levine, A. J., & Ott, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132268899 · Cited by 295 · see citing works
Self-citationRegulation of the Human hsp70 Promoter by p53
Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292 · see citing works
p53 Regulates the Expression of the Tumor Suppressor Gene Maspin
Zou, Z., Gao, C., Nagaich, A. K., Connell, T., Saito, S., Moul, J. W., Seth, P. K., Appella, E., & Srivastava, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6051 · Cited by 277 · see citing works
A functional p53-responsive intronic promoter is contained within the human<i>mdm2</i>gene
Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., & Oren, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2584 · Cited by 276 · see citing works
A polymorphic microsatellite that mediates induction of PIG3 by p53
Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M. (2002) · Nature Genetics · doi:10.1038/ng836 · Cited by 274 · see citing works
Bian, J., & Sun, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6330 · Cited by 274 · see citing works
Tan, M., Wang, Y., Guan, K., & Sun, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.109 · Cited by 253 · see citing works
Saramaki, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj460 · Cited by 251 · see citing works
Velasco-Miguel, S., Buckbinder, L., Jean, P., Gelbert, L., Talbott, R. L., Laidlaw, J. L., Seizinger, B. R., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202274 · Cited by 249 · see citing works
ASC is a Bax adaptor and regulates the p53–Bax mitochondrial apoptosis pathway
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Macip, S., Sagara, J., Nakayama, K. I., Aaronson, S. A., & Lee, S. W. (2004) · Nature Cell Biology · doi:10.1038/ncb1087 · Cited by 243 · see citing works
p53 alterations in human cancer: more questions than answers
Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 232 · see citing works
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Fei, P., Wang, W., Kim, S.-H., Wang, S., Burns, T. F., Sax, J. K., Buzzai, M., Dicker, D. T., McKenna, W. G., Bernhard, E. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.012 · Cited by 231 · see citing works
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227 · see citing works
A Biophysical Approach to Transcription Factor Binding Site DiscoveryPreprint
Djordjević, M., Sengupta, A. M., & Shraiman, B. I. (2003) · Genome Research · doi:10.1101/gr.1271603 · Cited by 226 · see citing works
Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity
Wu, G. S., Säftig, P., Peters, C., & El‐Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201755 · Cited by 226 · see citing works
Kanaya, T., Kyo, S., Hamada, K., Takakura, M., Kitagawa, Y., Harada, H., & Inoue, M. (2000) · PubMed · Cited by 222 · see citing works
Targets and mechanisms for the regulation of translation in malignant transformation
Clemens, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207544 · Cited by 222 · see citing works
NDRG1 Is Necessary for p53-dependent Apoptosis
Stein, S., Thomas, E. K., Herzog, B., Westfall, M. D., Rocheleau, J. V., Jackson, R. S., Wang, M., & Liang, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400386200 · Cited by 220 · see citing works
Burns, T. F., Fei, P., Scata, K. A., Dicker, D. T., & El‐Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5556-5571.2003 · Cited by 220 · see citing works
Liu, G., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205862 · Cited by 207 · see citing works
Comparative Binding of p53 to its Promoter and DNA Recognition Elements
Weinberg, R. L., Veprintsev, D. B., Bycroft, M., & Fersht, A. R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.014 · Cited by 206 · see citing works
Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters
Imbriano, C., Gurtner, A., Cocchiarella, F., Agostino, S. D., Basile, V., Gostissa, M., Dobbelstein, M., Sal, G. D., Piaggio, G., & Mantovani, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3737-3751.2005 · Cited by 205 · see citing works
Truant, R., Xiao, H., Ingles, C. J., & Greenblatt, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53769-8 · Cited by 203 · see citing works
Modeling dependencies in protein-DNA binding sites
Barash, Y., Elidan, G., Friedman, N., & Kaplan, T. (2003) · Research in Computational Molecular Biology · doi:10.1145/640075.640079 · Cited by 203 · see citing works
Inga, A., Storici, F., Darden, T. A., & Resnick, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8612-8625.2002 · Cited by 200 · see citing works
Wild‐type p53 adopts a ‘mutant’‐like conformation when bound to DNA.
Halazonetis, T. D., Davis, L. J., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05743.x · Cited by 193 · see citing works
APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Robles, A. I., Bemmels, N. A., Foraker, A. B., & Harris, C. C. (2001) · PubMed · Cited by 190 · see citing works
p53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding Site
Liu, X., Yue, P., Khuri, F. R., & Sun, S.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1195 · Cited by 184 · see citing works
Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183 · see citing works
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Muñoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 181 · see citing works
p53 tagged sites from human genomic DNA
Tokino, T., Thiagalingam, S., El‐Deiry, W. S., Waldman, T. A., Kinzler, K. W., & Vogelstein, B. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.9.1537 · Cited by 177 · see citing works
Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K., Todo, S., Mizuguchi, H., Hayakawa, T., & Nakagawara, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2575-2585.2002 · Cited by 176 · see citing works
p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding
Lee, K. C., Crowe, A. J., & Barton, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1279 · Cited by 176 · see citing works
p53 Binds and Activates the Xeroderma Pigmentosum <i>DDB2</i> Gene in Humans but Not Mice
Tan, T., & Chu, G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3247-3254.2002 · Cited by 167 · see citing works
Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches
Wang, L., Wu, Q. J., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P. T., Greene, J. R., Wang, Y., Pickett, C. B., & Liu, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106570200 · Cited by 164 · see citing works
Shou, J., Ali‐Osman, F., Multani, A. S., Pathak, S., Fedi, P., & Srivenugopal, K. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205138 · Cited by 164 · see citing works
Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53
Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205459 · Cited by 164 · see citing works
DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 162 · see citing works
Apoptotic threshold is lowered by p53 transactivation of caspase-6
MacLachlan, T. K., & El‐Deiry, W. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132241599 · Cited by 162 · see citing works
Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element
Johnson, R. A., Ince, T. A., & Scotto, K. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100121200 · Cited by 158 · see citing works
Ohlsson, C., Kley, N., Werner, H., & LeRoith, D. (1998) · Endocrinology · doi:10.1210/endo.139.3.5832 · Cited by 157 · see citing works
Bourdon, J., Chambon, V., Lelong, J., Dessen, P., May, P., Debuire, B., & May, E. (1997) · Oncogene · doi:10.1038/sj.onc.1200804 · Cited by 156 · see citing works
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
Yun, J., Chae, H., Choy, H. E., Chung, J., Yoo, H., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 155 · see citing works
Harms, K. L., & Chen, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4397 · Cited by 152 · see citing works
Interaction of p53 with Its Consensus DNA-Binding Site
Wang, Y., Schwedes, J. F., Parks, D., Mann, K., & Tegtmeyer, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2157 · Cited by 149 · see citing works
The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53
Mashimo, T., Watabe, M., Hirota, S., Hosobe, S., Miura, K., Tegtmeyer, P., Rinker-Schaeffer, C. W., & Watabe, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11307 · Cited by 149 · see citing works
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
Dohn, M. R., Jiang, J., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204816 · Cited by 146 · see citing works
McKinney, K. M., & Prives, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6797-6808.2002 · Cited by 146 · see citing works
Golubovskaya, V., Kaur, A. S., & Cance, W. G. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.03.002 · Cited by 145 · see citing works
Kunz, C., Pebler, S., Otte, J., & von der Ahe, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3710 · Cited by 144 · see citing works
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15237 · Cited by 144 · see citing works
Negative regulation of Rb expression by the p53 gene product.
Shiio, Y., Yamamoto, T., & Yamaguchi, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5206 · Cited by 136 · see citing works
Herzer, K., Falk, C. S., Encke, J., Eichhorst, S. T., Ulsenheimer, A., Seliger, B., & Krammer, P. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8299-8309.2003 · Cited by 134 · see citing works
Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63
Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A. I., Kim, M. S., Wu, G., Nomoto, S., Trink, B., & Sidransky, D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6077-6089.2005 · Cited by 134 · see citing works
Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M., & Manfredi, J. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205069 · Cited by 132 · see citing works
p53 oligomerization and DNA looping are linked with transcriptional activation.
Stenger, J. E., Tegtmeyer, P., Mayr, G. A., Reed, M. J., Wang, Y., Wang, P., Hough, P. V. C., & Mastrangelo, I. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06947.x · Cited by 131 · see citing works
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 130 · see citing works
Passer, B. J., Nancy-Portebois, V., Amzallag, N., Prieur, S., Cans, C., de Climens, A. R., Fiucci, G., Bouvard, V., Tuynder, M., Susini, L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530298100 · Cited by 130 · see citing works
Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53
Ueda, K., Arakawa, H., & Nakamura, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206845 · Cited by 126 · see citing works
p53 tumor suppressor protein regulates the levels of huntingtin gene expression
Feng, Z., Jin, S. V., Zupnick, A., Hoh, J., de Stanchina, E., Lowe, S. W., Prives, C. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209021 · Cited by 120 · see citing works
Self-citationIdentification of Novel p53 Target Genes in Ionizing Radiation Response
Jen, K., & Cheung, V. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1039 · Cited by 119 · see citing works
Maruyama, R., Aoki, F., Toyota, M., Sasaki, Y., Akashi, H., Mita, H., Suzuki, H., Akino, K., Ohe-Toyota, M., Maruyama, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2562 · Cited by 115 · see citing works
Farmer, G., Colgan, J. D., Nakatani, Y., Manley, J. L., & Prives, C. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4295 · Cited by 113 · see citing works
Chen, J., & Sadowski, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407069102 · Cited by 111 · see citing works
Han, H. J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1039 · Cited by 105 · see citing works
p53 Regulates Caveolin Gene Transcription, Cell Cholesterol, and Growth by a Novel Mechanism
Bist, A., Fielding, C. J., & Fielding, P. E. (2000) · Biochemistry · doi:10.1021/bi991721h · Cited by 104 · see citing works
The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation
Li, M., Zhou, J.-Y., Ge, Y., Matherly, L. H., & Wu, G. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307149200 · Cited by 103 · see citing works
Profile of gene expression regulated by induced p53: connection to the TGF‐β family
Kannan, K., Amariglio, N., Rechavi, G., & Givol, D. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01291-6 · Cited by 103 · see citing works
Scherer, S. J., Maier, S. M., Seifert, M., Hanselmann, R. G., Zang, K. D., Müller‐Hermelink, H. K., Angel, P. E., Welter, C., & Schartl, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006990200 · Cited by 102 · see citing works
Direct Transcriptional Activation of Human Caspase-1 by Tumor Suppressor p53
Gupta, S., Radha, V., Furukawa, Y., & Swarup, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100025200 · Cited by 98 · see citing works
Zhu, J., & Chen, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5602-5618.2000 · Cited by 98 · see citing works
Ori, A., Zauberman, A., Doitsh, G., Paran, N., Oren, M., & Shaul, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.544 · Cited by 97 · see citing works
Nylander, K., Bourdon, J., Bray, S. E., Gibbs, N. K., Kay, R. A., Hart, I. R., & Hall, P. A. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1 · Cited by 96 · see citing works
Yoon, H., Liyanarachchi, S., Wright, F. A., Davuluri, R. V., Lockman, J. C., de la Chapelle, A., & Pellegata, N. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242597299 · Cited by 94 · see citing works
Jung, M.-S., Yun, J., Chae, H., Kim, J., Kim, S., Choi, T.-S., & Shin, D. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204748 · Cited by 93 · see citing works
p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.
Peterson, E. J., Bögler, O., & Taylor, S. M. (2003) · PubMed · Cited by 93 · see citing works
p73 is transcriptionally regulated by DNA damage, p53, and p73
Chen, X., Zheng, Y., Zhu, J., Jiang, J., & Wang, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204149 · Cited by 92 · see citing works
Decoy Receptor 2 ( DcR2 ) Is a p53 Target Gene and Regulates Chemosensitivity
Liu, X., Yue, P., Khuri, F. R., & Sun, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0939 · Cited by 92 · see citing works
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells
Obad, S., Brunnström, H., Vallon-Christersson, J., Borg, Å., Drott, K., & Gullberg, U. (2004) · Oncogene · doi:10.1038/sj.onc.1207524 · Cited by 90 · see citing works
p53 is a NF‐Y‐ and p21‐independent, Sp1‐dependent repressor of cyclin B1 transcription
Innocente, S. A., & Lee, J. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.073 · Cited by 87 · see citing works
Harmes, D. C., Bresnick, E., Lubin, E. A., Watson, J. K., Heim, K. E., Curtin, J. C., Suskind, A. M., Lamb, J., & DiRenzo, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207129 · Cited by 85 · see citing works
A Genomic Map of p53 Binding Sites Identifies Novel p53 Targets Involved in an Apoptotic Network
Miled, C., Pontoglio, M., Garbay, S., Yaniv, M., & Weitzman, J. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4232 · Cited by 85 · see citing works
Thornborrow, E. C., & Manfredi, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011643200 · Cited by 85 · see citing works
Cloning of P2XM, a novel human P2X receptor gene regulated by p53.
Urano, T., Nishimori, H., Han, H., Furuhata, T., Kimura, Y., Nakamura, Y., & Tokino, T. (1997) · PubMed · Cited by 83 · see citing works
Zhang, C., Gao, C., Kawauchi, J., Hashimoto, Y., Tsuchida, N., & Kitajima, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02382-3 · Cited by 80 · see citing works
Shin, T. H., Paterson, A. J., & Kudlow, J. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4694 · Cited by 78 · see citing works
Saigusa, K., Imoto, I., Tanikawa, C., Aoyagi, M., Ohno, K., Nakamura, Y., & Inazawa, J. (2006) · Oncogene · doi:10.1038/sj.onc.1210148 · Cited by 77 · see citing works
Mortensen, K., Skouv, J., HOUGAARD, D. M., & Larsson, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37679 · Cited by 77 · see citing works
BLIMP1 regulates cell growth through repression of p53 transcription
Yan, J., Jiang, J., Lim, C. A., Wu, Q., Ng, H., & Chin, K.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605562104 · Cited by 75 · see citing works
Basile, V., Mantovani, R., & Imbriano, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507712200 · Cited by 75 · see citing works
Proteomics for the early detection and treatment of hepatocellular carcinoma
Feng, J.-T., Shang, S., & Beretta, L. (2006) · Oncogene · doi:10.1038/sj.onc.1209551 · Cited by 74 · see citing works
Farmer, G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4281 · Cited by 74 · see citing works
Duriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T., & Puisieux, A. (2002) · Gene · doi:10.1016/s0378-1119(01)00825-3 · Cited by 73 · see citing works
Identification of SCN3B as a novel p53-inducible proapoptotic gene
Adachi, K., Toyota, M., Sasaki, Y., Yamashita, T., Ishida, S., Ohe-Toyota, M., Maruyama, R., Hinoda, Y., Saito, T., Imai, K., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208067 · Cited by 72 · see citing works
Rozenfeld-Granot, G., Krishnamurthy, J., Kannan, K., Toren, A., Amariglio, N., Givol, D., & Rechavi, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205218 · Cited by 72 · see citing works
<i>p53CSV</i>, a Novel p53-Inducible Gene Involved in the p53-Dependent Cell-Survival Pathway
Park, W.-R., & Nakamura, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3339 · Cited by 72 · see citing works
Koutsodontis, G., Vasilaki, E., Chou, W., Papakosta, P., & Kardassis, D. (2005) · Biochemical Journal · doi:10.1042/bj20041980 · Cited by 70 · see citing works
p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers
Zhang, D. W., Jeang, K.-T., & Lee, C. G. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209220 · Cited by 69 · see citing works
Transcriptional activation of the human S100A2 promoter by wild‐type p53
Tan, M., Heizmann, C. W., Guan, K., Schäfer, B. W., & Sun, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00135-0 · Cited by 69 · see citing works
Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis
Sadasivam, S., Gupta, S., Radha, V., Batta, K., Kundu, T. K., & Swarup, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208201 · Cited by 63 · see citing works
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
Manfredi, J. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00106-0 · Cited by 63 · see citing works
Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53
Chun, A. C. S., & Jin, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307185200 · Cited by 60 · see citing works
Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.
Shiraishi, K., Fukuda, S., Mori, T., Matsuda, K., Yamaguchi, T., Tanikawa, C., Ogawa, M., Nakamura, Y., & Arakawa, H. (2000) · PubMed · Cited by 59 · see citing works
Warnick, C. T., Dabbas, B., Ford, C. D., & Strait, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103088200 · Cited by 59 · see citing works
Divergent Regulation of the Growth-promoting GeneIEX-1 by the p53 Tumor Suppressor and Sp1
Im, H., Pittelkow, M. R., & Kumar, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109414200 · Cited by 58 · see citing works
Dynamics of the p53 Acetylation Pathway
Gu, W., Luo, J., Brooks, C. L., Nikolaev, A. Y., & Li, M. (2004) · Novartis Foundation symposium · doi:10.1002/0470862637.ch14 · Cited by 57 · see citing works
Sun, Y., Zeng, X., Wenger, L., Firestein, G. S., & Cheung, H. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20044 · Cited by 57 · see citing works
Hearnes, J. M., Mays, D. J., Schavolt, K. L., Tang, L., Jiang, X. J., & Pietenpol, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10148-10158.2005 · Cited by 57 · see citing works
AMID is a p53-inducible gene downregulated in tumors
Wu, M., Xu, L., Su, T., Tian, Y., Zhai, Z., & Shu, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207909 · Cited by 56 · see citing works
Repression of hsp90β Gene by p53 in UV Irradiation-induced Apoptosis of Jurkat Cells
Zhang, Y., Wang, J., Chen, L., Zhang, Y., Cheng, X.-K., Heng, F.-Y., Wu, N., & Shen, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314213200 · Cited by 56 · see citing works
The second intron of the human galectin‐3 gene has a strong promoter activity down‐regulated by p53
Raimond, J., Rouleux‐Bonnin, F., Monsigny, M. L. P., & Legrand, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00310-6 · Cited by 55 · see citing works
p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206586 · Cited by 54 · see citing works
Prats, A., & Prats, H. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72075-8 · Cited by 53 · see citing works
Benoît, V., Hellin, A., Huygen, S., GIELEN, J. E., Bours, V., & Merville, M.-P. (2000) · Oncogene · doi:10.1038/sj.onc.1203831 · Cited by 52 · see citing works
Regulation of the c-met Proto-oncogene Promoter by p53
Seol, D., Chen, Q., Smith, M. L., & Zarnegar, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3565 · Cited by 51 · see citing works
Margalit, O., Amram, H. W., Amariglio, N., Simon, A. J., Shaklai, S., Granot, G., Minsky, N., Shimoni, A., Harmelin, A., Givol, D., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1629 · Cited by 51 · see citing works
p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene
Kubicka, S., Kühnel, F., Zender, L., Rudolph, K. L., Plümpe, J., Manns, M. P., & Trautwein, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32137 · Cited by 50 · see citing works
Kato, M. V., Sato, H., Nagayoshi, M., & Ikawa, Y. (1997) · Blood · doi:10.1182/blood.v90.4.1373 · Cited by 50 · see citing works
Rollwagen, F. M., Yu, Z.-Y., Li, Y., & Pacheco, N. D. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4600 · Cited by 49 · see citing works
Jaiswal, A. S., & Narayan, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101298200 · Cited by 49 · see citing works
Britschgi, C., Rizzi, M., Grob, T. J., Tschan, M. P., Hügli, B., Reddy, V. A., Andres, A. ‐., Torbett, B. E., Tobler, A., & Fey, M. F. (2005) · Oncogene · doi:10.1038/sj.onc.1209240 · Cited by 49 · see citing works
Multiple response elements and differential p53 binding control Perp expression during apoptosis.
Reczek, E. E., Flores, E. R., Tsay, A. S., Attardi, L. D., & Jacks, T. (2003) · PubMed · Cited by 49 · see citing works
Cyclin K as a Direct Transcriptional Target of the p53 Tumor Suppressor
Mori, T., Anazawa, Y., Matsui, K., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Neoplasia · doi:10.1038/sj.neo.7900235 · Cited by 48 · see citing works
Repression of New p53 Targets Revealed by ChIP on Chip Experiments
Ceribelli, M., Alcalay, M., Viganò, M., & Mantovani, R. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2777 · Cited by 48 · see citing works
Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47 · see citing works
Caspase 10 Levels are Increased Following DNA Damage in a p53-Dependent Manner
Rikhof, B., Corn, P. G., & El‐Deiry, W. S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.626 · Cited by 43 · see citing works
The Bradykinin Type 2 Receptor Is a Target for p53-mediated Transcriptional Activation
Saifudeen, Z. R., Du, H., Dipp, S., & El-Dahr, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909810199 · Cited by 38 · see citing works
E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53.
Ma, K., Araki, K., Ichwan, S. J. A., Suganuma, T., Tamamori‐Adachi, M., & Ikeda, M. (2003) · PubMed · Cited by 38 · see citing works
Receptor protein tyrosine kinase DDR is up‐regulated by p53 protein
Sakuma, S., Saya, H., Tada, M., Nakao, M., Fujiwara, T., Roth, J. A., Sawamura, Y., Shinohe, Y., & Abe, H. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01234-3 · Cited by 37 · see citing works
Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein.
Iotsova, V., & Stéhelin, D. (1996) · PubMed · Cited by 35 · see citing works
Kimura, Y., Furuhata, T., Urano, T., Hirata, K., Nakamura, Y., & Tokino, T. (1997) · Genomics · doi:10.1006/geno.1997.4680 · Cited by 31 · see citing works
Wild-Type But Not Mutant p53 Activates the Hepatocyte Growth Factor/Scatter Factor Promoter
Metcalfe, A. M. J., Dixon, R. M., & Radda, G. K. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.5.983 · Cited by 29 · see citing works
Chambon, V., Vacher, M., Jullien, M., May, E., & Bourdon, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203960 · Cited by 28 · see citing works
P53 Activates Fanconi Anemia Group C Gene Expression
Liebetrau, W., Budde, A., Savoia, A., Grummt, F., & Hoehn, H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.277 · Cited by 27 · see citing works
Cytoplasmic complex of p53 and eEF2
Yin, X., Fontoura, B. M. A., Morimoto, T., & Carroll, R. B. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10329 · Cited by 26 · see citing works
Structure and Chromosomal Assignment of the Human Cyclin G Gene
Endo, Y., Fujita, T., Tamura, K., Tsuruga, H., & Nojima, H. (1996) · Genomics · doi:10.1006/geno.1996.0598 · Cited by 23 · see citing works
Wild-type p53 activates SAP expression in lymphoid cells
Nagy, N., Takahara, M., Nishikawa, J., Bourdon, J., Kis, L. L., Klein, G., & Klein, E. (2004) · Oncogene · doi:10.1038/sj.onc.1207908 · Cited by 22 · see citing works
Atomic force microscopy reveals kinks in the p53 response element DNA
Balagurumoorthy, P., Lindsay, S., & Harrington, R. E. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00169-2 · Cited by 22 · see citing works
Cook, J. L., Rn, R., Jf, G., Fe, F., Dy, C., & Alam, J. (1995) · PubMed · Cited by 16 · see citing works
The ribosomal 5.8S RNA as a target site for p53 protein in cell differentiation and oncogenesis
Elela, S. A., & Nazar, R. N. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00196-1 · Cited by 14 · see citing works
Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53
Chae, H., Yun, J., & Shi, D. Y. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.60 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · see citing works
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368 · see citing works
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199 · see citing works
Self-consumption: the interplay of autophagy and apoptosis
Mariño, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3735 · Cited by 2,172 · see citing works
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053 · see citing works
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395 · see citing works
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384 · see citing works
Unravelling mechanisms of p53-mediated tumour suppression
Bieging-Rolett, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3711 · Cited by 1,389 · see citing works
Crosstalk between apoptosis.; necrosis and autophagy
Nikoletopoulou, V., Markaki, M., Palikaras, K., & Tavernarakis, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.001 · Cited by 1,366 · see citing works
The Cell–Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
Chen, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026104 · Cited by 1,222 · see citing works
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · see citing works
Mutant p53: one name, many proteinsPreprint
Freed-Pastor, W. A., & Prives, C. L. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,246 · see citing works
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
Sengupta, S., Peterson, T. R., & Sabatini, D. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.026 · Cited by 1,234 · see citing works
Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182 · see citing works
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129 · see citing works
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106 · see citing works
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080 · see citing works
Roles, Functions, and Mechanisms of Long Non-Coding RNAs in Cancer
Fang, Y., & Fullwood, M. J. (2016) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.09.006 · Cited by 1,072 · see citing works
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · see citing works
iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections
Janky, R., Verfaillie, A., Imrichová, H., Van de Sande, B., Standaert, L., Christiaens, V., Hulselmans, G., Herten, K., Naval Sanchez, M., Potier, D., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003731 · Cited by 900 · see citing works
“Identification of the TFs that operate a perturbed gene network, and detecting their target genes, are instrumental steps in uncovering key insights into oncogenic programs, including the discovery of therapeutic targets [9–12].”
BackgroundTargeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016 · see citing works
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884 · see citing works
p53 Dynamics Control Cell Fate
Purvis, J. E., Karhohs, K. W., Mock, C., Batchelor, E., Loewer, A., & Lahav, G. (2012) · Science · doi:10.1126/science.1218351 · Cited by 770 · see citing works
Long Non-Coding RNA in the Pathogenesis of Cancers
Chi, Y., Wang, D., Wang, J., Yu, W., & Yang, J. (2019) · Cells · doi:10.3390/cells8091015 · Cited by 780 · see citing works
p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740 · see citing works
S100B's double life: Intracellular regulator and extracellular signal
Donato, R., Sorci, G., Riuzzi, F., Arcuri, C., Bianchi, R., Brozzi, F., Tubaro, C., & Giambanco, I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.009 · Cited by 728 · see citing works
The genetics of the p53 pathway, apoptosis and cancer therapy
Vázquez, A., Bond, E. E., Levine, A. J., & Bond, G. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2656 · Cited by 674 · see citing works
Self-citationp53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. C. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2584 · Cited by 667 · see citing works
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637 · see citing works
“INTRODUCTION p53 is an crucial tumor suppressor that is mutated in more than 50% of human cancers and whose major function is regulating cell fate after cellular stress and repressing the propagation of damaged cells (Lane, 1992; Riley et al., 2008; Vogelstein et al., 2000).”
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2716 · Cited by 604 · see citing works
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569 · see citing works
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568 · see citing works
Tumor Suppressive Functions of p53Preprint
Zilfou, J. T., & Lowe, S. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001883 · Cited by 572 · see citing works
Chemistry and biochemistry of lipid peroxidation products
Guéraud, F., Atalay, M., Bresgen, N., Gašparović, A. Č., Eckl, P., Laurence Therese, H. U. C., Jouanin, I., Siems, W., & Uchida, K. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498477 · Cited by 556 · see citing works
Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Brady, C. A., Jiang, D., Mello, S. S., Johnson, T. M., Jarvis, L. A., Kozak, M. M., Broz, D. K., Basak, S., Park, E. J., McLaughlin, M. E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.035 · Cited by 533 · see citing works
Oxidative stress and pulmonary fibrosis
Cheresh, P., Kim, S.-J., Tulasiram, S., & Kamp, D. W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.021 · Cited by 527 · see citing works
MicroRNAs in the p53 network: micromanagement of tumour suppression
Hermeking, H. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3318 · Cited by 518 · see citing works
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 461 · see citing works
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence
Jiang, P., Du, W., Mancuso, A., Wellen, K. E., & Yang, X. (2013) · Nature · doi:10.1038/nature11776 · Cited by 491 · see citing works
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Zhou, J., Kang, Y., Chen, L., Wang, H., Liu, J., Zeng, S., & Yu, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00343 · Cited by 481 · see citing works
Kenzelmann Broz, D., Spano Mello, S., Bieging, K. T., Jiang, D., Dusek, R. L., Brady, C. A., Sidow, A., & Attardi, L. D. (2013) · Genes & Development · doi:10.1101/gad.212282.112 · Cited by 443 · see citing works
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Kim, N. H., Kim, H. S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201103097 · Cited by 432 · see citing works
Tunneling-nanotube development in astrocytes depends on p53 activation
Wang, Y., Cui, J., Sun, X., & Zhang, Y. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.147 · Cited by 416 · see citing works
Reactive Oxygen Species in Normal and Tumor Stem Cells
Zhou, D.-H., Shao, L.-J., & Spitz, D. (2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-420117-0.00001-3 · Cited by 323 · see citing works
TP53 Mutations in Nonsmall Cell Lung Cancer
Mogi, A., & Kuwano, H. (2011) · BioMed Research International · doi:10.1155/2011/583929 · Cited by 392 · see citing works
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Choi, Y. J., Lin, C., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 381 · see citing works
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Moustafa, A. A., & Malki, M. I. (2020) · Cancers · doi:10.3390/cancers12041050 · Cited by 378 · see citing works
Brady, C. A., & Attardi, L. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.064501 · Cited by 374 · see citing works
Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330 · see citing works
The Origin of Allosteric Functional Modulation: Multiple Pre-existing Pathways
del Sol, A., Tsai, C., Ma, B., & Nussinov, R. (2009) · Structure · doi:10.1016/j.str.2009.06.008 · Cited by 365 · see citing works
Jackson, J. G., Pant, V., Li, Q., Chang, L. L., Quintás-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.027 · Cited by 329 · see citing works
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Wang, L., Wu, C., Rajasekaran, N., & Shin, Y. K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495956 · Cited by 335 · see citing works
p53 Acetylation: Regulation and Consequences
Reed, S. M., & Quelle, D. E. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 330 · see citing works
TGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
Samarakoon, R., Overstreet, J. M., & Higgins, P. J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.10.003 · Cited by 333 · see citing works
Tumor-Suppressor Functions of the TP53 PathwayPreprint
Aubrey, B. J., Strasser, A., & Kelly, G. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026062 · Cited by 331 · see citing works
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Bhutia, Y. D., & Ganapathy, V. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.017 · Cited by 326 · see citing works
Allele-Specific p53 Mutant Reactivation
Yu, X., Vázquez, A., Levine, A. J., & Carpizo, D. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.042 · Cited by 320 · see citing works
Self-citationThe p53 family and programmed cell death
Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.315 · Cited by 314 · see citing works
Cao, L., Xu, X., Bunting, S. F., Liu, J., Wang, R.-H., Cao, L. L., Wu, J. J., Peng, T.-N., Chen, J., Nussenzweig, A., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.037 · Cited by 308 · see citing works
p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, N.-G., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308 · see citing works
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppressionPreprint
Okada, N., Lin, C., Ribeiro, M. C., Biton, A., Lai, G., He, X., Bu, P., Vogel, H. S., Jablons, D. M., Keller, A., et al. (2014) · Genes & Development · doi:10.1101/gad.233585.113 · Cited by 297 · see citing works
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.008 · Cited by 295 · see citing works
The IKK complex contributes to the induction of autophagy
Criollo, A., Senovilla, L., Authier, H., Maiuri, M. C., Morselli, E., Vitale, I., Kepp, O., Tasdemir, E., Galluzzi, L., Shen, S., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.364 · Cited by 296 · see citing works
Schwitalla, S., Ziegler, P. K., Horst, D., Becker, V., Kerle, I., Begus-Nahrmann, Y., Lechel, A., Rudolph, K. L., Langer, R., Slotta-Huspenina, J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.014 · Cited by 296 · see citing works
Cell-to-cell variation in p53 dynamics leads to fractional killing.
Paek, A. L., Liu, J. C., Loewer, A., Forrester, W. C., & Lahav, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.025 · Cited by 292 · see citing works
The same, only different – DNA damage checkpoints and their reversal throughout the cell cycle
Shaltiël, I. A., Krenning, L., Bruinsma, W., & Medema, R. H. (2015) · Journal of Cell Science · doi:10.1242/jcs.163766 · Cited by 289 · see citing works
Valente, L. J., Gray, D. H. D., Michalak, E. M., Hofbauer, J. P., Egle, A., Scott, C. L., Janic, A., & Strasser, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.012 · Cited by 292 · see citing works
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 291 · see citing works
Canale, M., Petracci, E., Delmonte, A., Chiadini, E., Dazzi, C., Papi, M., Capelli, L., Casanova, C., De Luigi, N., Mariotti, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0966 · Cited by 288 · see citing works
Kotler, E., Shani, O., Goldfeld, G., Lotan‐Pompan, M., Tarcic, O., Gershoni, A., Hopf, T. A., Marks, D. S., Oren, M., & Segal, E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.012 · Cited by 287 · see citing works
Negative regulation of the tumor suppressor p53 gene by microRNAs
Kumar, M., Lu, Z., Takwi, A. A., Chen, W., Callander, N. S., Ramos, K. S., Young, K. H., & Li, Y. (2010) · Oncogene · doi:10.1038/onc.2010.457 · Cited by 284 · see citing works
Cellular Stress Response Pathway System as a Sentinel Ensemble in Toxicological Screening
Simmons, S. O., Fan, C., & Ramabhadran, R. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp140 · Cited by 280 · see citing works
Mechanisms of Endothelial Dysfunction, Injury, and Death
Pober, J. S., Wang, M., & Bradley, J. R. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092155 · Cited by 272 · see citing works
Tumor suppressor p53 and its mutants in cancer metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.025 · Cited by 266 · see citing works
de Castro, D. G., Martı́nez, P., Wade, R. L., Hockley, S. L., Oscier, D. G., Matutes, E., Dearden, C. E., Richards, S. M., Catovsky, D., & Morgan, G. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0838 · Cited by 270 · see citing works
Regulation of autophagy by stress-responsive transcription factors
Pietrocola, F., Izzo, V., Niso‐Santano, M., Vacchelli, E., Galluzzi, L., Maiuri, M. C., & Kroemer, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.008 · Cited by 270 · see citing works
Reciprocal influence of the p53 and the hypoxic pathways
Sermeus, A., & Michiels, C. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.48 · Cited by 267 · see citing works
ARMMs as a versatile platform for intracellular delivery of macromolecules
Wang, Q., Yu, J., Kadungure, T., Beyene, J., Zhang, H., & Lu, Q. (2018) · Nature Communications · doi:10.1038/s41467-018-03390-x · Cited by 275 · see citing works
Sensitivity of Salivary Glands to Radiation: from Animal Models to Therapies
Grundmann, O., Mitchell, G. C., & Limesand, K. H. (2009) · Journal of Dental Research · doi:10.1177/0022034509343143 · Cited by 262 · see citing works
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.
Kracikova, M., Akiri, G., George, A., Sachidanandam, R., & Aaronson, S. A. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.155 · Cited by 261 · see citing works
Leonova, K. I., Brodsky, L., Lipchick, B. C., Pal, M., Novototskaya, L. R., Chenchik, A. A., Sen, G. C., Komarova, E. A., & Gudkov, A. V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216922110 · Cited by 261 · see citing works
The p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 252 · see citing works
Self-citationTargeting p53 for Novel Anticancer Therapy
Wang, Z., & Sun, Y. (2010) · Translational Oncology · doi:10.1593/tlo.09250 · Cited by 249 · see citing works
Mutant p53 in cancer therapy—the barrier or the path
Zhou, X. Y., Hao, Q., & Lu, H. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy072 · Cited by 244 · see citing works
Sotiropoulou, P. A., Candi, A., Mascré, G., Clercq, S. D., Youssef, K. K., Lapouge, G., Dahl, E., Semeraro, C., Denecker, G., Marine, J., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2059 · Cited by 245 · see citing works
The ups and downs of p53: understanding protein dynamics in single cells
Batchelor, E., Loewer, A., & Lahav, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2604 · Cited by 242 · see citing works
A nuclear poly(ADP-Ribose)-dependent signalosome confers DNA damage-induced IκB kinase activation.
Stilmann, M., Hinz, M., Arslan, S. Ç., Zimmer, A., Schreiber, V., & Scheidereit, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.032 · Cited by 232 · see citing works
Mdm2 Regulates p53 mRNA Translation through Inhibitory Interactions with Ribosomal Protein L26
Ofir-Rosenfeld, Y., Boggs, K., Michael, D., Kastan, M. B., & Oren, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.031 · Cited by 240 · see citing works
Schulz‐Heddergott, R., Stark, N., Edmunds, S. J., Li, J., Conradi, L., Bohnenberger, H., Ceteci, F., Greten, F. R., Dobbelstein, M., & Moll, U. M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.004 · Cited by 239 · see citing works
Allen, M. A., Andrysík, Z., Dengler, V. L., Mellert, H. S., Guarnieri, A. L., Freeman, J. A., Sullivan, K. D., Galbraith, M. D., Luo, X., Kraus, W. L., et al. (2014) · eLife · doi:10.7554/elife.02200 · Cited by 238 · see citing works
Role of p53 in breast cancer progression: An insight into p53 targeted therapy
Marvalim, C., Datta, A., & Lee, S. C. (2023) · Theranostics · doi:10.7150/thno.81847 · Cited by 243 · see citing works
Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells
Loewer, A., Batchelor, E., Gaglia, G., & Lahav, G. (2010) · Cell · doi:10.1016/j.cell.2010.05.031 · Cited by 234 · see citing works
Shi, Y., Nikulenkov, F., Zawacka‐Pankau, J., Li, H., Gabdoulline, R. R., Xu, J., Eriksson, S. E., Hedström, E., Issaeva, N., Kel, A. E., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.186 · Cited by 232 · see citing works
TAp73 enhances the pentose phosphate pathway and supports cell proliferation
Du, W., Jiang, P., Mancuso, A., Stonestrom, A. J., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 234 · see citing works
Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
Jiang, L., Hickman, J. H., Wang, S.-J., & Gu, W. J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1068479 · Cited by 232 · see citing works
Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Sørensen, B. S., & Horsman, M. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00562 · Cited by 231 · see citing works
Regulation of cellular miRNA expression by human papillomaviruses
Zheng, Z., & Wang, X. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.005 · Cited by 225 · see citing works
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
Procopio, M.-G., Laszlo, C., Al Labban, D., Kim, D. E., Bordignon, P., Jo, S.-H., Goruppi, S., Menietti, E., Ostano, P., Ala, U., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3228 · Cited by 223 · see citing works
- Authors
- Riley, T., Sontag, E., Chen, P., & Levine, A.
- Affiliations
- Institute for Advanced Study (US)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Riley, Todd
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-05
- Volume
- 9
- Issue
- 5
- Pages
- 402-412
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1964719993
- Cited by
- 1,921
- References
- 201
- Citations by year
- 2026: 36 · 2025: 45 · 2024: 56 · 2023: 73 · 2022: 85 · 2021: 97 · 2020: 79 · 2019: 92 · 2018: 110 · 2017: 134 · 2016: 131 · 2015: 115 · 2014: 154 · 2013: 143 · 2012: 153
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- p53, transcriptional regulation, p53 target genes, DNA damage response, DNA repair, cell cycle arrest, senescence, apoptosis, tumor suppression, transcription factor binding sites, stress signaling
- MeSH terms
- Base Sequence, Binding Sites, Cell Transformation, Neoplastic, DNA Damage, Gene Expression Regulation, Humans, Markov Chains, Molecular Sequence Data, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Signal Transduction, Genes, p53, Tumor Suppressor Protein p53, Response Elements, Regulatory Elements, Transcriptional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review